Spectral AI (MDAI) announced that the Company’s DeepView System has been featured in the journal Burns as part of a clinical study in which it achieved a 95.3% overall accuracy assessment as compared to traditional subjective assessments. Chris Lewis, a lead author of the study, said “We are thrilled to see our experience with the DeepView technology published in Burns. This research highlights the transformative role of this cutting-edge technology in evaluating burn depth. By providing clinicians with data-driven insights, DeepView empowers earlier decision-making regarding healing time and the necessity of surgical debridement, ultimately improving patient outcomes. The study represents the first multi-center evaluation of AI-enhanced multispectral imaging in burn assessment which demonstrates the DeepView System’s effectiveness across diverse clinical settings. Being published in Burns is a testament to the clinical importance of the DeepView device. The technology is not only innovative but also has the potential to revolutionize burn care on a global scale.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDAI:
- Spectral AI Earnings Call Highlights Progress and Challenges
- Spectral AI price target lowered to $2 from $3 at BTIG
- Spectral AI’s Promising Outlook: Strong Financials, Strategic Expense Management, and Key Milestone Achievements
- Spectral AI Reports Strong Q1 2025 Results
- Spectral AI files to sell 2.84M shares of common stock for holders
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue